STOCK TITAN

Boston Scientific Elects Dr. Jessica L. Mega and Susan E. Morano to Board of Directors

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
management
Rhea-AI Summary
Boston Scientific Corporation announces the election of Dr. Jessica L. Mega and Susan E. Morano to its board of directors.
Positive
  • Dr. Jessica L. Mega, co-founder of Verily Life Sciences LLC, and Susan E. Morano, former vice president at Johnson & Johnson, join Boston Scientific's board of directors. Their expertise in healthcare and innovative technologies will contribute to the company's growth and stakeholder commitments.
Negative
  • None.

MARLBOROUGH, Mass., June 27, 2023 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) announced today the election of Dr. Jessica L. Mega and Susan E. Morano to its board of directors, each effective immediately.

Dr. Mega is the co-founder of Verily Life Sciences LLC, a subsidiary of Alphabet Inc. focused on life sciences and healthcare, and was the company's chief medical and scientific officer from 2015 to January 2023. Prior to joining Verily, Dr. Mega served as a cardiologist at Brigham & Women's Hospital from 2008 to 2015. Dr. Mega also served as a faculty member at Harvard Medical School and as a senior investigator with the TIMI Study Group, where she led international trials evaluating novel cardiovascular therapies and directed the genomics program. She currently is a director of Danaher Corporation. Dr. Mega received her B.A. from Stanford University, her M.D. from Yale University School of Medicine, and her M.P.H. from Harvard School of Public Health.

Ms. Morano held the role of vice president, Business Development and Strategic Operations, Johnson & Johnson MedTech from 2020 through February 2023. Prior to that, she served as vice president, Business Development, Johnson & Johnson Medical Devices, beginning in 2012, with responsibility for licensing, acquisitions and divestitures for its Medical Devices Group. During her time at Johnson & Johnson, Ms. Morano also held several positions within six operating companies, primarily in the finance and business development functions, and as a member of the MedTech Leadership Team. Ms. Morano received her B.S. from Villanova University and her M.B.A. from Columbia Business School.

"We are pleased to expand our board of directors with two highly qualified executives from different sectors of the healthcare industry," said Mike Mahoney, chief executive and chairman of the board, Boston Scientific. "Jessica and Susan are accomplished leaders passionate about advancing patient care and experienced in bringing innovative technologies to market, and we look forward to their contributions as board members as Boston Scientific continues to grow and meet our stakeholder commitments."

About Boston Scientific
Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world.  As a global medical technology leader for more than 40 years, we advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare. For more information, visit www.bostonscientific.com and connect on Twitter and Facebook.

CONTACTS



Media:


Investors:

Emily Anderson


Lauren Tengler

617-515-2000 (office)


508-683-4479 (office)

Media Relations


Investor Relations

Boston Scientific Corporation


Boston Scientific Corporation

Emily.Anderson2@bsci.com


BSXInvestorRelations@bsci.com




 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/boston-scientific-elects-dr-jessica-l-mega-and-susan-e-morano-to-board-of-directors-301864104.html

SOURCE Boston Scientific Corporation

FAQ

Who are the new members of Boston Scientific's board of directors?

Dr. Jessica L. Mega and Susan E. Morano.

What is Dr. Jessica L. Mega's background?

Dr. Jessica L. Mega is the co-founder of Verily Life Sciences LLC and has a background in life sciences and healthcare. She previously served as the chief medical and scientific officer at Verily.

What is Susan E. Morano's background?

Susan E. Morano previously held roles at Johnson & Johnson, including vice president of Business Development and Strategic Operations at Johnson & Johnson MedTech.

What is the significance of these appointments?

The addition of Dr. Jessica L. Mega and Susan E. Morano to the board of directors brings expertise in healthcare, innovative technologies, and patient care to Boston Scientific.

Boston Scientific Corp.

NYSE:BSX

BSX Rankings

BSX Latest News

BSX Stock Data

106.66B
1.46B
0.19%
93.66%
0.85%
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
United States of America
MARLBOROUGH

About BSX

Boston Scientific Corp. engages in the development, manufacture and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments.